Td Waterhouse Canada Inc. Bellus Health Inc. Transaction History

Td Waterhouse Canada Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Nov 13, 2023	SELL	$0.0 - $14.75 $0 - $15,708	-1,065 Closed	0 $0
Q4 2022 Nov 13, 2023	SELL	$8.22 - $10.76 $12,741 - $16,678	-1,550 Reduced 59.27%	1,065 $12.1 Million
Q3 2022 Nov 13, 2023	BUY	$8.95 - $12.0 $13,872 - $18,600	1,550 Added 145.54%	2,615 $37.1 Million
Q2 2022 Nov 13, 2023	BUY	$6.46 - $10.02 $6,634 - $10,290	1,027 Added 2702.63%	1,065 $12.8 Million
Q4 2021 Nov 13, 2023	BUY	$5.26 - $8.3 $199 - $315	38 New	38 $361,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.